APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood-derived Products

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Blood-derived Products Market Analysis and Forecast 2026-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchBlood-derived Products Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood-derived Products Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Blood-derived Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood-derived Products Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood-derived Products Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Blood-derived Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Blood-derived Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Blood-derived Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Blood-derived Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Blood-derived Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Blood-derived Products include Yuanda Shuyang, Takeda, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Shanghai RAAS, Hualan Bio, Boya Bio and CBPO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Blood-derived Products, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Blood-derived Products, also provides the sales of main regions and countries. Of the upcoming market potential for Blood-derived Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood-derived Products sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Blood-derived Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Blood-derived Products sales, projected growth trends, production technology, application and end-user industry.

Blood-derived Products Segment by Company

Yuanda Shuyang

Takeda

Weiguang Bio

Tiantan Bio

Shuanglin Bio

Shanghai RAAS

Hualan Bio

Boya Bio

CBPO

Octapharma

LFB Group

Kedrion

Grifols

CSL

Blood-derived Products Segment by Type

Coagulation Factors

Immunoglobulins

Albumin

Others

Blood-derived Products Segment by Application

Therapeutics

Excipient

Other

Blood-derived Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood-derived Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood-derived Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood-derived Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Blood-derived Products in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Blood-derived Products manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood-derived Products sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blood-derived Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Coagulation Factors Major Manufacturers Table 3. Immunoglobulins Major Manufacturers Table 4. Albumin Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Blood-derived Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Therapeutics Major Manufacturers Table 8. Excipient Major Manufacturers Table 9. Other Major Manufacturers Table 10. Blood-derived Products Industry Trends Table 11. Blood-derived Products Industry Drivers Table 12. Blood-derived Products Industry Opportunities and Challenges Table 13. Blood-derived Products Industry Restraints Table 14. Global Blood-derived Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Blood-derived Products Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Blood-derived Products Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Blood-derived Products Revenue Market Share by Region (2021-2026) Table 18. Global Blood-derived Products Revenue Market Share by Region (2027-2032) Table 19. Global Blood-derived Products Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 20. Global Blood-derived Products Sales by Region (2021-2026) & (t) Table 21. Global Blood-derived Products Sales by Region (2027-2032) & (t) Table 22. Global Blood-derived Products Sales Market Share by Region (2021-2026) Table 23. Global Blood-derived Products Sales Market Share by Region (2027-2032) Table 24. Global Blood-derived Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Blood-derived Products Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Blood-derived Products Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Blood-derived Products Sales Market Share by Manufacturers (2021-2026) Table 28. Global Blood-derived Products Sales Price (USD/kg) of Manufacturers (2021-2026) Table 29. Global Blood-derived Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Blood-derived Products Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Blood-derived Products Manufacturers, Product Type & Application Table 32. Global Blood-derived Products Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Blood-derived Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Blood-derived Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Blood-derived Products Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Blood-derived Products Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Blood-derived Products Revenue Market Share by Type (2021-2026) Table 39. Global Blood-derived Products Revenue Market Share by Type (2027-2032) Table 40. Global Blood-derived Products Sales by Type 2021 VS 2025 VS 2032 (t) Table 41. Global Blood-derived Products Sales by Type (2021-2026) & (t) Table 42. Global Blood-derived Products Sales by Type (2027-2032) & (t) Table 43. Global Blood-derived Products Sales Market Share by Type (2021-2026) Table 44. Global Blood-derived Products Sales Market Share by Type (2027-2032) Table 45. Global Blood-derived Products Price by Type (2021-2026) & (USD/kg) Table 46. Global Blood-derived Products Price by Type (2027-2032) & (USD/kg) Table 47. Global Blood-derived Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Blood-derived Products Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Blood-derived Products Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Blood-derived Products Revenue Market Share by Application (2021-2026) Table 51. Global Blood-derived Products Revenue Market Share by Application (2027-2032) Table 52. Global Blood-derived Products Sales by Application 2021 VS 2025 VS 2032 (t) Table 53. Global Blood-derived Products Sales by Application (2021-2026) & (t) Table 54. Global Blood-derived Products Sales by Application (2027-2032) & (t) Table 55. Global Blood-derived Products Sales Market Share by Application (2021-2026) Table 56. Global Blood-derived Products Sales Market Share by Application (2027-2032) Table 57. Global Blood-derived Products Price by Application (2021-2026) & (USD/kg) Table 58. Global Blood-derived Products Price by Application (2027-2032) & (USD/kg) Table 59. Yuanda Shuyang Company Information Table 60. Yuanda Shuyang Business Overview Table 61. Yuanda Shuyang Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 62. Yuanda Shuyang Blood-derived Products Product Portfolio Table 63. Yuanda Shuyang Recent Development Table 64. Takeda Company Information Table 65. Takeda Business Overview Table 66. Takeda Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 67. Takeda Blood-derived Products Product Portfolio Table 68. Takeda Recent Development Table 69. Weiguang Bio Company Information Table 70. Weiguang Bio Business Overview Table 71. Weiguang Bio Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 72. Weiguang Bio Blood-derived Products Product Portfolio Table 73. Weiguang Bio Recent Development Table 74. Tiantan Bio Company Information Table 75. Tiantan Bio Business Overview Table 76. Tiantan Bio Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 77. Tiantan Bio Blood-derived Products Product Portfolio Table 78. Tiantan Bio Recent Development Table 79. Shuanglin Bio Company Information Table 80. Shuanglin Bio Business Overview Table 81. Shuanglin Bio Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 82. Shuanglin Bio Blood-derived Products Product Portfolio Table 83. Shuanglin Bio Recent Development Table 84. Shanghai RAAS Company Information Table 85. Shanghai RAAS Business Overview Table 86. Shanghai RAAS Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 87. Shanghai RAAS Blood-derived Products Product Portfolio Table 88. Shanghai RAAS Recent Development Table 89. Hualan Bio Company Information Table 90. Hualan Bio Business Overview Table 91. Hualan Bio Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 92. Hualan Bio Blood-derived Products Product Portfolio Table 93. Hualan Bio Recent Development Table 94. Boya Bio Company Information Table 95. Boya Bio Business Overview Table 96. Boya Bio Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 97. Boya Bio Blood-derived Products Product Portfolio Table 98. Boya Bio Recent Development Table 99. CBPO Company Information Table 100. CBPO Business Overview Table 101. CBPO Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 102. CBPO Blood-derived Products Product Portfolio Table 103. CBPO Recent Development Table 104. Octapharma Company Information Table 105. Octapharma Business Overview Table 106. Octapharma Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 107. Octapharma Blood-derived Products Product Portfolio Table 108. Octapharma Recent Development Table 109. LFB Group Company Information Table 110. LFB Group Business Overview Table 111. LFB Group Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 112. LFB Group Blood-derived Products Product Portfolio Table 113. LFB Group Recent Development Table 114. Kedrion Company Information Table 115. Kedrion Business Overview Table 116. Kedrion Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 117. Kedrion Blood-derived Products Product Portfolio Table 118. Kedrion Recent Development Table 119. Grifols Company Information Table 120. Grifols Business Overview Table 121. Grifols Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 122. Grifols Blood-derived Products Product Portfolio Table 123. Grifols Recent Development Table 124. CSL Company Information Table 125. CSL Business Overview Table 126. CSL Blood-derived Products Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 127. CSL Blood-derived Products Product Portfolio Table 128. CSL Recent Development Table 129. North America Blood-derived Products Revenue by Type (2021-2026) & (US$ Million) Table 130. North America Blood-derived Products Revenue by Type (2027-2032) & (US$ Million) Table 131. North America Blood-derived Products Sales by Type (2021-2026) & (t) Table 132. North America Blood-derived Products Sales by Type (2027-2032) & (t) Table 133. North America Blood-derived Products Sales Price by Type (2021-2026) & (USD/kg) Table 134. North America Blood-derived Products Sales Price by Type (2027-2032) & (USD/kg) Table 135. North America Blood-derived Products Revenue by Application (2021-2026) & (US$ Million) Table 136. North America Blood-derived Products Revenue by Application (2027-2032) & (US$ Million) Table 137. North America Blood-derived Products Sales by Application (2021-2026) & (t) Table 138. North America Blood-derived Products Sales by Application (2027-2032) & (t) Table 139. North America Blood-derived Products Sales Price by Application (2021-2026) & (USD/kg) Table 140. North America Blood-derived Products Sales Price by Application (2027-2032) & (USD/kg) Table 141. North America Blood-derived Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America Blood-derived Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. North America Blood-derived Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. North America Blood-derived Products Sales by Country (2021 VS 2025 VS 2032) & (t) Table 145. North America Blood-derived Products Sales by Country (2021-2026) & (t) Table 146. North America Blood-derived Products Sales by Country (2027-2032) & (t) Table 147. North America Blood-derived Products Sales Price by Country (2021-2026) & (USD/kg) Table 148. North America Blood-derived Products Sales Price by Country (2027-2032) & (USD/kg) Table 149. United States Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 150. Canada Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 151. Mexico Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 152. Europe Blood-derived Products Revenue by Type (2021-2026) & (US$ Million) Table 153. Europe Blood-derived Products Revenue by Type (2027-2032) & (US$ Million) Table 154. Europe Blood-derived Products Sales by Type (2021-2026) & (t) Table 155. Europe Blood-derived Products Sales by Type (2027-2032) & (t) Table 156. Europe Blood-derived Products Sales Price by Type (2021-2026) & (USD/kg) Table 157. Europe Blood-derived Products Sales Price by Type (2027-2032) & (USD/kg) Table 158. Europe Blood-derived Products Revenue by Application (2021-2026) & (US$ Million) Table 159. Europe Blood-derived Products Revenue by Application (2027-2032) & (US$ Million) Table 160. Europe Blood-derived Products Sales by Application (2021-2026) & (t) Table 161. Europe Blood-derived Products Sales by Application (2027-2032) & (t) Table 162. Europe Blood-derived Products Sales Price by Application (2021-2026) & (USD/kg) Table 163. Europe Blood-derived Products Sales Price by Application (2027-2032) & (USD/kg) Table 164. Europe Blood-derived Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Europe Blood-derived Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Europe Blood-derived Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Europe Blood-derived Products Sales by Country (2021 VS 2025 VS 2032) & (t) Table 168. Europe Blood-derived Products Sales by Country (2021-2026) & (t) Table 169. Europe Blood-derived Products Sales by Country (2027-2032) & (t) Table 170. Europe Blood-derived Products Sales Price by Country (2021-2026) & (USD/kg) Table 171. Europe Blood-derived Products Sales Price by Country (2027-2032) & (USD/kg) Table 172. Germany Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 173. France Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 174. U.K. Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 175. Italy Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 176. Russia Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 177. Spain Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 178. Netherlands Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 179. Switzerland Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 180. Sweden Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 181. Poland Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 182. China Blood-derived Products Revenue by Type (2021-2026) & (US$ Million) Table 183. China Blood-derived Products Revenue by Type (2027-2032) & (US$ Million) Table 184. China Blood-derived Products Sales by Type (2021-2026) & (t) Table 185. China Blood-derived Products Sales by Type (2027-2032) & (t) Table 186. China Blood-derived Products Sales Price by Type (2021-2026) & (USD/kg) Table 187. China Blood-derived Products Sales Price by Type (2027-2032) & (USD/kg) Table 188. China Blood-derived Products Revenue by Application (2021-2026) & (US$ Million) Table 189. China Blood-derived Products Revenue by Application (2027-2032) & (US$ Million) Table 190. China Blood-derived Products Sales by Application (2021-2026) & (t) Table 191. China Blood-derived Products Sales by Application (2027-2032) & (t) Table 192. China Blood-derived Products Sales Price by Application (2021-2026) & (USD/kg) Table 193. China Blood-derived Products Sales Price by Application (2027-2032) & (USD/kg) Table 194. Asia Blood-derived Products Revenue by Type (2021-2026) & (US$ Million) Table 195. Asia Blood-derived Products Revenue by Type (2027-2032) & (US$ Million) Table 196. Asia Blood-derived Products Sales by Type (2021-2026) & (t) Table 197. Asia Blood-derived Products Sales by Type (2027-2032) & (t) Table 198. Asia Blood-derived Products Sales Price by Type (2021-2026) & (USD/kg) Table 199. Asia Blood-derived Products Sales Price by Type (2027-2032) & (USD/kg) Table 200. Asia Blood-derived Products Revenue by Application (2021-2026) & (US$ Million) Table 201. Asia Blood-derived Products Revenue by Application (2027-2032) & (US$ Million) Table 202. Asia Blood-derived Products Sales by Application (2021-2026) & (t) Table 203. Asia Blood-derived Products Sales by Application (2027-2032) & (t) Table 204. Asia Blood-derived Products Sales Price by Application (2021-2026) & (USD/kg) Table 205. Asia Blood-derived Products Sales Price by Application (2027-2032) & (USD/kg) Table 206. Asia Blood-derived Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Asia Blood-derived Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Asia Blood-derived Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Asia Blood-derived Products Sales by Country (2021 VS 2025 VS 2032) & (t) Table 210. Asia Blood-derived Products Sales by Country (2021-2026) & (t) Table 211. Asia Blood-derived Products Sales by Country (2027-2032) & (t) Table 212. Asia Blood-derived Products Sales Price by Country (2021-2026) & (USD/kg) Table 213. Asia Blood-derived Products Sales Price by Country (2027-2032) & (USD/kg) Table 214. Japan Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 215. South Korea Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 216. India Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 217. Australia Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 218. Taiwan Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 219. Southeast Asia Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 220. SAMEA Blood-derived Products Revenue by Type (2021-2026) & (US$ Million) Table 221. SAMEA Blood-derived Products Revenue by Type (2027-2032) & (US$ Million) Table 222. SAMEA Blood-derived Products Sales by Type (2021-2026) & (t) Table 223. SAMEA Blood-derived Products Sales by Type (2027-2032) & (t) Table 224. SAMEA Blood-derived Products Sales Price by Type (2021-2026) & (USD/kg) Table 225. SAMEA Blood-derived Products Sales Price by Type (2027-2032) & (USD/kg) Table 226. SAMEA Blood-derived Products Revenue by Application (2021-2026) & (US$ Million) Table 227. SAMEA Blood-derived Products Revenue by Application (2027-2032) & (US$ Million) Table 228. SAMEA Blood-derived Products Sales by Application (2021-2026) & (t) Table 229. SAMEA Blood-derived Products Sales by Application (2027-2032) & (t) Table 230. SAMEA Blood-derived Products Sales Price by Application (2021-2026) & (USD/kg) Table 231. SAMEA Blood-derived Products Sales Price by Application (2027-2032) & (USD/kg) Table 232. SAMEA Blood-derived Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 233. SAMEA Blood-derived Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 234. SAMEA Blood-derived Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 235. SAMEA Blood-derived Products Sales by Country (2021 VS 2025 VS 2032) & (t) Table 236. SAMEA Blood-derived Products Sales by Country (2021-2026) & (t) Table 237. SAMEA Blood-derived Products Sales by Country (2027-2032) & (t) Table 238. SAMEA Blood-derived Products Sales Price by Country (2021-2026) & (USD/kg) Table 239. SAMEA Blood-derived Products Sales Price by Country (2027-2032) & (USD/kg) Table 240. Brazil Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 241. Argentina Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 242. Chile Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 243. Colombia Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 244. Peru Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 245. Saudi Arabia Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 246. Israel Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 247. UAE Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 248. Turkey Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 249. Iran Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 250. Egypt Blood-derived Products Revenue (2021-2032) & (US$ Million) Table 251. Key Raw Materials Table 252. Raw Materials Key Suppliers Table 253. Blood-derived Products Distributors List Table 254. Blood-derived Products Customers List Table 255. Research Programs/Design for This Report Table 256. Authors List of This Report Table 257. Secondary Sources Table 258. Primary Sources List of Figures Figure 1. Blood-derived Products Image Figure 2. Global Blood-derived Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood-derived Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. Coagulation Factors Image Figure 5. Immunoglobulins Image Figure 6. Albumin Image Figure 7. Others Image Figure 8. Global Blood-derived Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Blood-derived Products Market Size Share 2021 VS 2025 VS 2032 Figure 10. Therapeutics Image Figure 11. Excipient Image Figure 12. Other Image Figure 13. Global Blood-derived Products Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Blood-derived Products Revenue (2021-2032) & (US$ Million) Figure 15. Global Blood-derived Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Blood-derived Products Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Blood-derived Products Revenue Market Share by Region (2021-2032) Figure 18. Global Blood-derived Products Sales (2021-2032) & (t) Figure 19. Global Blood-derived Products Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 20. Global Blood-derived Products Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Blood-derived Products Sales YoY (2021-2032) & (t) Figure 22. Europe Blood-derived Products Sales YoY (2021-2032) & (t) Figure 23. China Blood-derived Products Sales YoY (2021-2032) & (t) Figure 24. Asia (Excluding China) Blood-derived Products Sales YoY (2021-2032) & (t) Figure 25. South America, Middle East and Africa Blood-derived Products Sales YoY (2021-2032) & (t) Figure 26. Global Blood-derived Products Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Blood-derived Products Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Blood-derived Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Blood-derived Products Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Blood-derived Products Revenue Market Share by Type (2021-2032) Figure 32. Global Blood-derived Products Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 33. Global Blood-derived Products Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Blood-derived Products Sales Market Share by Type (2021-2032) Figure 35. Global Blood-derived Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Blood-derived Products Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Blood-derived Products Revenue Market Share by Application (2021-2032) Figure 38. Global Blood-derived Products Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 39. Global Blood-derived Products Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Blood-derived Products Sales Market Share by Application (2021-2032) Figure 41. North America Blood-derived Products Revenue Share by Type (2021-2032) Figure 42. North America Blood-derived Products Sales Share by Type (2021-2032) Figure 43. North America Blood-derived Products Revenue Share by Application (2021-2032) Figure 44. North America Blood-derived Products Sales Share by Application (2021-2032) Figure 45. North America Blood-derived Products Revenue Share by Country (2021-2032) Figure 46. North America Blood-derived Products Sales Share by Country (2021-2032) Figure 47. Europe Blood-derived Products Revenue Share by Type (2021-2032) Figure 48. Europe Blood-derived Products Sales Share by Type (2021-2032) Figure 49. Europe Blood-derived Products Revenue Share by Application (2021-2032) Figure 50. Europe Blood-derived Products Sales Share by Application (2021-2032) Figure 51. Europe Blood-derived Products Revenue Share by Country (2021-2032) Figure 52. Europe Blood-derived Products Sales Share by Country (2021-2032) Figure 53. China Blood-derived Products Revenue Share by Type (2021-2032) Figure 54. China Blood-derived Products Sales Share by Type (2021-2032) Figure 55. China Blood-derived Products Revenue Share by Application (2021-2032) Figure 56. China Blood-derived Products Sales Share by Application (2021-2032) Figure 57. Asia Blood-derived Products Revenue Share by Type (2021-2032) Figure 58. Asia Blood-derived Products Sales Share by Type (2021-2032) Figure 59. Asia Blood-derived Products Revenue Share by Application (2021-2032) Figure 60. Asia Blood-derived Products Sales Share by Application (2021-2032) Figure 61. Asia Blood-derived Products Revenue Share by Country (2021-2032) Figure 62. Asia Blood-derived Products Sales Share by Country (2021-2032) Figure 63. SAMEA Blood-derived Products Revenue Share by Type (2021-2032) Figure 64. SAMEA Blood-derived Products Sales Share by Type (2021-2032) Figure 65. SAMEA Blood-derived Products Revenue Share by Application (2021-2032) Figure 66. SAMEA Blood-derived Products Sales Share by Application (2021-2032) Figure 67. SAMEA Blood-derived Products Revenue Share by Country (2021-2032) Figure 68. SAMEA Blood-derived Products Sales Share by Country (2021-2032) Figure 69. Blood-derived Products Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Blood-derived Products Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Coagulation Factors
  • Immunoglobulins
  • Albumin
  • Others
Applications
  • Therapeutics
  • Excipient
  • Other
Companies covered
  • Yuanda Shuyang
  • Takeda
  • Weiguang Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Shanghai RAAS
  • Hualan Bio
  • Boya Bio
  • CBPO
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Blood-derived Products Market by Type
  3. 1.2.1 Global Blood-derived Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Coagulation Factors
  5. 1.2.3 Immunoglobulins
  6. 1.2.4 Albumin
  7. 1.2.5 Others
  8. 1.3 Blood-derived Products Market by Application
  9. 1.3.1 Global Blood-derived Products Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Therapeutics
  11. 1.3.3 Excipient
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Blood-derived Products Market Dynamics
  1. 2.1 Blood-derived Products Industry Trends
  2. 2.2 Blood-derived Products Industry Drivers
  3. 2.3 Blood-derived Products Industry Opportunities and Challenges
  4. 2.4 Blood-derived Products Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Blood-derived Products Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Blood-derived Products Revenue by Region
  3. 3.2.1 Global Blood-derived Products Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Blood-derived Products Revenue by Region (2021-2026)
  5. 3.2.3 Global Blood-derived Products Revenue by Region (2027-2032)
  6. 3.2.4 Global Blood-derived Products Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Blood-derived Products Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Blood-derived Products Sales by Region
  9. 3.4.1 Global Blood-derived Products Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Blood-derived Products Sales by Region (2021-2026)
  11. 3.4.3 Global Blood-derived Products Sales by Region (2027-2032)
  12. 3.4.4 Global Blood-derived Products Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Blood-derived Products Revenue by Manufacturers
  2. 4.1.1 Global Blood-derived Products Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Blood-derived Products Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Blood-derived Products Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Blood-derived Products Sales by Manufacturers
  6. 4.2.1 Global Blood-derived Products Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Blood-derived Products Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Blood-derived Products Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Blood-derived Products Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Blood-derived Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Blood-derived Products Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Blood-derived Products Manufacturers, Product Type & Application
  13. 4.7 Global Blood-derived Products Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Blood-derived Products Market CR5 and HHI
  16. 4.8.2 2025 Blood-derived Products Tier 1, Tier 2, and Tier 3
5 Blood-derived Products Market by Type
  1. 5.1 Global Blood-derived Products Revenue by Type
  2. 5.1.1 Global Blood-derived Products Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Blood-derived Products Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Blood-derived Products Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Blood-derived Products Sales by Type
  6. 5.2.1 Global Blood-derived Products Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood-derived Products Sales by Type (2021-2032) & (t)
  8. 5.2.3 Global Blood-derived Products Sales Market Share by Type (2021-2032)
  9. 5.3 Global Blood-derived Products Price by Type
6 Blood-derived Products Market by Application
  1. 6.1 Global Blood-derived Products Revenue by Application
  2. 6.1.1 Global Blood-derived Products Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Blood-derived Products Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Blood-derived Products Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Blood-derived Products Sales by Application
  6. 6.2.1 Global Blood-derived Products Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Blood-derived Products Sales by Application (2021-2032) & (t)
  8. 6.2.3 Global Blood-derived Products Sales Market Share by Application (2021-2032)
  9. 6.3 Global Blood-derived Products Price by Application
7 Company Profiles
  1. 7.1 Yuanda Shuyang
  2. 7.1.1 Yuanda Shuyang Company Information
  3. 7.1.2 Yuanda Shuyang Business Overview
  4. 7.1.3 Yuanda Shuyang Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Yuanda Shuyang Blood-derived Products Product Portfolio
  6. 7.1.5 Yuanda Shuyang Recent Developments
  7. 7.2 Takeda
  8. 7.2.1 Takeda Company Information
  9. 7.2.2 Takeda Business Overview
  10. 7.2.3 Takeda Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Takeda Blood-derived Products Product Portfolio
  12. 7.2.5 Takeda Recent Developments
  13. 7.3 Weiguang Bio
  14. 7.3.1 Weiguang Bio Company Information
  15. 7.3.2 Weiguang Bio Business Overview
  16. 7.3.3 Weiguang Bio Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Weiguang Bio Blood-derived Products Product Portfolio
  18. 7.3.5 Weiguang Bio Recent Developments
  19. 7.4 Tiantan Bio
  20. 7.4.1 Tiantan Bio Company Information
  21. 7.4.2 Tiantan Bio Business Overview
  22. 7.4.3 Tiantan Bio Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tiantan Bio Blood-derived Products Product Portfolio
  24. 7.4.5 Tiantan Bio Recent Developments
  25. 7.5 Shuanglin Bio
  26. 7.5.1 Shuanglin Bio Company Information
  27. 7.5.2 Shuanglin Bio Business Overview
  28. 7.5.3 Shuanglin Bio Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shuanglin Bio Blood-derived Products Product Portfolio
  30. 7.5.5 Shuanglin Bio Recent Developments
  31. 7.6 Shanghai RAAS
  32. 7.6.1 Shanghai RAAS Company Information
  33. 7.6.2 Shanghai RAAS Business Overview
  34. 7.6.3 Shanghai RAAS Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai RAAS Blood-derived Products Product Portfolio
  36. 7.6.5 Shanghai RAAS Recent Developments
  37. 7.7 Hualan Bio
  38. 7.7.1 Hualan Bio Company Information
  39. 7.7.2 Hualan Bio Business Overview
  40. 7.7.3 Hualan Bio Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hualan Bio Blood-derived Products Product Portfolio
  42. 7.7.5 Hualan Bio Recent Developments
  43. 7.8 Boya Bio
  44. 7.8.1 Boya Bio Company Information
  45. 7.8.2 Boya Bio Business Overview
  46. 7.8.3 Boya Bio Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Boya Bio Blood-derived Products Product Portfolio
  48. 7.8.5 Boya Bio Recent Developments
  49. 7.9 CBPO
  50. 7.9.1 CBPO Company Information
  51. 7.9.2 CBPO Business Overview
  52. 7.9.3 CBPO Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 CBPO Blood-derived Products Product Portfolio
  54. 7.9.5 CBPO Recent Developments
  55. 7.10 Octapharma
  56. 7.10.1 Octapharma Company Information
  57. 7.10.2 Octapharma Business Overview
  58. 7.10.3 Octapharma Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Octapharma Blood-derived Products Product Portfolio
  60. 7.10.5 Octapharma Recent Developments
  61. 7.11 LFB Group
  62. 7.11.1 LFB Group Company Information
  63. 7.11.2 LFB Group Business Overview
  64. 7.11.3 LFB Group Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 LFB Group Blood-derived Products Product Portfolio
  66. 7.11.5 LFB Group Recent Developments
  67. 7.12 Kedrion
  68. 7.12.1 Kedrion Company Information
  69. 7.12.2 Kedrion Business Overview
  70. 7.12.3 Kedrion Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Kedrion Blood-derived Products Product Portfolio
  72. 7.12.5 Kedrion Recent Developments
  73. 7.13 Grifols
  74. 7.13.1 Grifols Company Information
  75. 7.13.2 Grifols Business Overview
  76. 7.13.3 Grifols Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Grifols Blood-derived Products Product Portfolio
  78. 7.13.5 Grifols Recent Developments
  79. 7.14 CSL
  80. 7.14.1 CSL Company Information
  81. 7.14.2 CSL Business Overview
  82. 7.14.3 CSL Blood-derived Products Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 CSL Blood-derived Products Product Portfolio
  84. 7.14.5 CSL Recent Developments
8 North America
  1. 8.1 North America Blood-derived Products Market Size by Type
  2. 8.1.1 North America Blood-derived Products Revenue by Type (2021-2032)
  3. 8.1.2 North America Blood-derived Products Sales by Type (2021-2032)
  4. 8.1.3 North America Blood-derived Products Price by Type (2021-2032)
  5. 8.2 North America Blood-derived Products Market Size by Application
  6. 8.2.1 North America Blood-derived Products Revenue by Application (2021-2032)
  7. 8.2.2 North America Blood-derived Products Sales by Application (2021-2032)
  8. 8.2.3 North America Blood-derived Products Price by Application (2021-2032)
  9. 8.3 North America Blood-derived Products Market Size by Country
  10. 8.3.1 North America Blood-derived Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Blood-derived Products Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Blood-derived Products Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Blood-derived Products Market Size by Type
  2. 9.1.1 Europe Blood-derived Products Revenue by Type (2021-2032)
  3. 9.1.2 Europe Blood-derived Products Sales by Type (2021-2032)
  4. 9.1.3 Europe Blood-derived Products Price by Type (2021-2032)
  5. 9.2 Europe Blood-derived Products Market Size by Application
  6. 9.2.1 Europe Blood-derived Products Revenue by Application (2021-2032)
  7. 9.2.2 Europe Blood-derived Products Sales by Application (2021-2032)
  8. 9.2.3 Europe Blood-derived Products Price by Application (2021-2032)
  9. 9.3 Europe Blood-derived Products Market Size by Country
  10. 9.3.1 Europe Blood-derived Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Blood-derived Products Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Blood-derived Products Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Blood-derived Products Market Size by Type
  2. 10.1.1 China Blood-derived Products Revenue by Type (2021-2032)
  3. 10.1.2 China Blood-derived Products Sales by Type (2021-2032)
  4. 10.1.3 China Blood-derived Products Price by Type (2021-2032)
  5. 10.2 China Blood-derived Products Market Size by Application
  6. 10.2.1 China Blood-derived Products Revenue by Application (2021-2032)
  7. 10.2.2 China Blood-derived Products Sales by Application (2021-2032)
  8. 10.2.3 China Blood-derived Products Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Blood-derived Products Market Size by Type
  2. 11.1.1 Asia Blood-derived Products Revenue by Type (2021-2032)
  3. 11.1.2 Asia Blood-derived Products Sales by Type (2021-2032)
  4. 11.1.3 Asia Blood-derived Products Price by Type (2021-2032)
  5. 11.2 Asia Blood-derived Products Market Size by Application
  6. 11.2.1 Asia Blood-derived Products Revenue by Application (2021-2032)
  7. 11.2.2 Asia Blood-derived Products Sales by Application (2021-2032)
  8. 11.2.3 Asia Blood-derived Products Price by Application (2021-2032)
  9. 11.3 Asia Blood-derived Products Market Size by Country
  10. 11.3.1 Asia Blood-derived Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Blood-derived Products Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Blood-derived Products Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Blood-derived Products Market Size by Type
  2. 12.1.1 SAMEA Blood-derived Products Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Blood-derived Products Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Blood-derived Products Price by Type (2021-2032)
  5. 12.2 SAMEA Blood-derived Products Market Size by Application
  6. 12.2.1 SAMEA Blood-derived Products Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Blood-derived Products Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Blood-derived Products Price by Application (2021-2032)
  9. 12.3 SAMEA Blood-derived Products Market Size by Country
  10. 12.3.1 SAMEA Blood-derived Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Blood-derived Products Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Blood-derived Products Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Blood-derived Products Value Chain Analysis
  2. 13.1.1 Blood-derived Products Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Blood-derived Products Production Mode & Process
  6. 13.2 Blood-derived Products Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Blood-derived Products Distributors
  9. 13.2.3 Blood-derived Products Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst